{"filing":{"accession_number":"0001193125-26-254590","cik":"0001590877","ticker":"RGNX","company_name":"REGENXBIO Inc.","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"rgnx-20260529.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/rgnx-20260529.htm"},"events":[{"id":7132,"run_id":6258,"accession_number":"0001193125-26-254590","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"REGENXBIO held its 2026 Annual Meeting of Shareholders on May 29, 2026, with final voting results disclosed for five proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, approval of a stock option exchange program for non-executive employees, and rejection of a stock option exchange program for executive employees.","company_name":"REGENXBIO Inc.","ticker":"RGNX","filing_date":"2026-06-03","form":"8-K","submitted_at":null,"items":[{"id":3930,"accession_number":"0001193125-26-254590","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from REGENXBIO's 2026 Annual Meeting held on May 29, 2026, covering five proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, approval of a stock option exchange program for non-executive employees, and rejection of a stock option exchange program for executive employees. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:28.206174+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":7133,"run_id":6258,"accession_number":"0001193125-26-254590","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"summary":"REGENXBIO commenced a shareholder-approved Stock Option Exchange Program permitting non-executive employees to exchange underwater stock options with an exercise price of $18.00 or greater for new options granted at fair market value, affecting the company's equity incentive structure.","company_name":"REGENXBIO Inc.","ticker":"RGNX","filing_date":"2026-06-03","form":"8-K","submitted_at":null,"items":[{"id":3931,"accession_number":"0001193125-26-254590","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"REGENXBIO commenced a shareholder-approved Stock Option Exchange Program allowing non-executive employees to exchange underwater options (exercise price ≥$18.00) for new options at fair market value. While this is a compensatory arrangement affecting equity incentives, it does not fit cleanly into exec_compensation (which typically addresses named executives or board-level compensation decisions) nor any other specific category. The program's material nature—affecting employee equity holdings and shareholder-approved capital structure—warrants disclosure as a material event, but the absence of a dedicated taxonomy entry makes other_material most appropriate.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:28.206174+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3930,"accession_number":"0001193125-26-254590","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from REGENXBIO's 2026 Annual Meeting held on May 29, 2026, covering five proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, approval of a stock option exchange program for non-executive employees, and rejection of a stock option exchange program for executive employees. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:28.206174+00:00","company_name":"REGENXBIO Inc.","ticker":"RGNX","filing_date":"2026-06-03"},{"id":3931,"accession_number":"0001193125-26-254590","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"REGENXBIO commenced a shareholder-approved Stock Option Exchange Program allowing non-executive employees to exchange underwater options (exercise price ≥$18.00) for new options at fair market value. While this is a compensatory arrangement affecting equity incentives, it does not fit cleanly into exec_compensation (which typically addresses named executives or board-level compensation decisions) nor any other specific category. The program's material nature—affecting employee equity holdings and shareholder-approved capital structure—warrants disclosure as a material event, but the absence of a dedicated taxonomy entry makes other_material most appropriate.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:28.206174+00:00","company_name":"REGENXBIO Inc.","ticker":"RGNX","filing_date":"2026-06-03"}]}